PULM
PULM clinical trials: Pulmatrix, Inc.
Every trial on ClinicalTrials.gov where Pulmatrix, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 16
- Trials linked
- 15
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PULM on the catalyst calendar · PULM registry changes
- Primary completion Feb 27, 2024ActualPhase 2NCT05667662Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPAPulmatrix Inc. · ABPATerminatedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 22, 2022ActualPhase 1NCT05351086A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health AdultsPulmatrix Inc. · HealthyCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2, 2021ActualPhase 1NCT04759807A Phase 1b Study of PUR1800 in Patients With COPDPulmatrix Inc. · Chronic Obstructive Pulmonary Disease (COPD)CompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 14, 2020ActualPhase 2NCT03960606Study in Adult Asthmatic Patients With Allergic Bronchopulmonary AspergillosisPulmatrix Inc. · Allergic Bronchopulmonary AspergillosisTerminatedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2015ActualPhase 1/Phase 2NCT02280395A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60Pulmatrix Inc. · Postoperative Wound Infection-deepTerminatedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 28, 2018ActualPhase 1NCT03479411Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With AsthmaPulmatrix Inc. · AsthmaCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2009ActualPhase 1NCT00947687Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult SubjectsPulmatrix Inc. · HealthyCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2016ActualPhase 1NCT02671825A PK Study to Evaluate PUR0200 and a Reference Product in Healthy SubjectsPulmatrix Inc. · HealthyCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2014ActualPhase 1NCT0219896321 Day Cumulative Skin Irritation of RUT058-60Pulmatrix Inc. · Irritation/IrritantCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2013ActualPhase 1NCT01921712A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD PatientsPulmatrix Inc. · Chronic Obstructive Pulmonary Disease (COPD)CompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2013ActualPhase 1NCT01690949Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal VolunteersPulmatrix Inc. · Chronic Obstructive Pulmonary Disease (COPD)CompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2012ActualPhase 1NCT01543191A Safety and Tolerability Study OF PUR118 In Subjects With Cystic FibrosisPulmatrix Inc. · Cystic FibrosisCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2012ActualPhase 1NCT01333904Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118Pulmatrix Inc. · Chronic Obstructive Pulmonary DiseaseCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2011ActualPhase 1NCT00989521Effect of PUR003 on AsthmaPulmatrix Inc. · AsthmaCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2010ActualNo phase registeredNCT01096173Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmonary Disease (COPD) SputumPulmatrix Inc. · Chronic Obstructive Pulmonary DiseaseCompletedPULMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 10, 2024ActualNo phase registeredNCT05903612Allergic Bronchopulmonary Aspergillosis Prescreening StudyCommunity Pharmacology Services Ltd · Allergic Bronchopulmonary AspergillosisWithdrawnPULMCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 16 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner